Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 350.7K | 1.0M | 410.8K | 291.4K |
Selling general and admin | 338.1K | 944.4K | 237.0K | 249.8K |
Other operating expenses | -445.0K | -185K | -100K | — |
Operating income | -243.8K | -1.8M | -547.8K | -541.1K |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 0 | 10.0K | 3.6K | 7.7K |
Other income expense | 2 | -360 | 2.4M | — |
Pretax income | -243.8K | -1.8M | 1.9M | -548.8K |
Tax provision | 0 | 0 | 0 | 0 |
Net income | -243.8K | -1.8M | 1.9M | -548.8K |
Basic EPS | 0.0 | — | 0.0 | 0.0 |
Diluted EPS | 0.0 | — | 0.0 | 0.0 |
Basic average shares | 308.5M | — | 303.1M | 302.8M |
Diluted average shares | 308.5M | — | 316.9M | 302.8M |
EBITDA | -213.9K | -1.7M | -518.1K | -511.5K |
Net income from continuing op. | -243.8K | -1.8M | 1.9M | -548.8K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |